CA1140470A - Aluminum chloride and aluminum zirconium hydroxychloride as antiperspirant - Google Patents
Aluminum chloride and aluminum zirconium hydroxychloride as antiperspirantInfo
- Publication number
- CA1140470A CA1140470A CA000355786A CA355786A CA1140470A CA 1140470 A CA1140470 A CA 1140470A CA 000355786 A CA000355786 A CA 000355786A CA 355786 A CA355786 A CA 355786A CA 1140470 A CA1140470 A CA 1140470A
- Authority
- CA
- Canada
- Prior art keywords
- composition
- aluminum
- antiperspirant
- chloride
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 title claims abstract description 29
- 230000001166 anti-perspirative effect Effects 0.000 title claims abstract description 27
- 239000003213 antiperspirant Substances 0.000 title claims abstract description 27
- -1 aluminum zirconium hydroxychloride Chemical compound 0.000 title claims abstract description 16
- 239000000203 mixture Substances 0.000 claims abstract description 39
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000004471 Glycine Substances 0.000 claims abstract description 12
- 239000000463 material Substances 0.000 claims abstract description 10
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 claims abstract description 7
- 239000000347 magnesium hydroxide Substances 0.000 claims abstract description 7
- 229910001862 magnesium hydroxide Inorganic materials 0.000 claims abstract description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 5
- 239000000443 aerosol Substances 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 239000006210 lotion Substances 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 3
- 239000006260 foam Substances 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims description 2
- 229910052751 metal Inorganic materials 0.000 claims description 2
- 239000002184 metal Substances 0.000 claims description 2
- 239000003002 pH adjusting agent Substances 0.000 claims description 2
- 239000000395 magnesium oxide Substances 0.000 claims 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims 2
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical class [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 claims 2
- 230000007794 irritation Effects 0.000 abstract description 3
- 239000002552 dosage form Substances 0.000 abstract description 2
- 239000003638 chemical reducing agent Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical group O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 4
- 239000003974 emollient agent Substances 0.000 description 4
- 235000012254 magnesium hydroxide Nutrition 0.000 description 4
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- JKXYOQDLERSFPT-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-octadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO JKXYOQDLERSFPT-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000006172 buffering agent Substances 0.000 description 2
- 229940000425 combination drug Drugs 0.000 description 2
- 229960002380 dibutyl phthalate Drugs 0.000 description 2
- 150000004679 hydroxides Chemical class 0.000 description 2
- FMXLGOWFNZLJQK-UHFFFAOYSA-N hypochlorous acid;zirconium Chemical compound [Zr].ClO FMXLGOWFNZLJQK-UHFFFAOYSA-N 0.000 description 2
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- OVBJJZOQPCKUOR-UHFFFAOYSA-L EDTA disodium salt dihydrate Chemical compound O.O.[Na+].[Na+].[O-]C(=O)C[NH+](CC([O-])=O)CC[NH+](CC([O-])=O)CC([O-])=O OVBJJZOQPCKUOR-UHFFFAOYSA-L 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- ZGUQGPFMMTZGBQ-UHFFFAOYSA-N [Al].[Al].[Zr] Chemical compound [Al].[Al].[Zr] ZGUQGPFMMTZGBQ-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- VBLGVPQPJHMPAD-UHFFFAOYSA-G aluminum;zirconium(4+);heptahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Al+3].[Zr+4] VBLGVPQPJHMPAD-UHFFFAOYSA-G 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000013066 combination product Substances 0.000 description 1
- 229940127555 combination product Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000001282 iso-butane Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/28—Zirconium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
ABSTRACT OF THE DISCLOSURE
An antiperspirant composition is disclosed having any of a variety of dosage forms and contain-ing as active antiperspirant materials a combination of an aluminum chloride and an aluminum zirconium hydroxychloride in certain ratios which act syner-gistically; the product may also contain a combination of magnesium hydroxide (or oxide) and glycine as irritation reducing agents.
An antiperspirant composition is disclosed having any of a variety of dosage forms and contain-ing as active antiperspirant materials a combination of an aluminum chloride and an aluminum zirconium hydroxychloride in certain ratios which act syner-gistically; the product may also contain a combination of magnesium hydroxide (or oxide) and glycine as irritation reducing agents.
Description
7~
ANTIPERSPIRANT CO~D?OSITION CONTAINING AS
ACTIVE ANTIPERSPIR~NT AGENTS AN ALU~INUM CHLORIDE
AND AN ALUMINUM ZIRCONIUM HYDROXYCHLORIDE AND METHOD
This invention relates to novel antiperspirant compositions. More particularly, it concerns antiperspir-ant compositions containing as active ingredients a com-bination of an aluminum chloride and an aluminum zirconium hydroxychloride.
It is known in the prior art to use aluminum chloride or aluminum zirconium hydroxychlorida individually as anti-perspirant materials. We have now found 7 however, when these materials are employed together they act syneryis-tically giving unexpected high activity and response rate.
It is accordingly an object of the present invention to provide a high performance antiperspirant composition containiny as active antiperspirant material a combination of an alumînum chloride and an al~lminum zirconium hydroxy-chloride.
It is also an object of the present invention to provide a method for inhibiting perspiration in subjects by applying to the skin of such subjects an antiperspirant effective amount of compositions containing in combination an aluminum chloride and an aluminum zirconium hydroxychloride.
Other and more d~tailed objects o~ this invention will be apparent from the following description and claims.
Unless otherwise indicated the percentages are given in percent by weight based on the total weight of the compo-sition.
It is known that certain types of people will respond to particular types of antiperspirant salts; it being unusual to find more than 60-70% of an antiperspirant panel respond-ing to any one given material. However, when the combination of active ingredients of this invention was used over 93%
of the panel participants responded favorably. Additionally, surprisingly high activities were recorded; 88~ had superior activity. It has always been believed that the activity mechanism for different salts differ~ What has been dis-covered here is a combination product that allows activity responses from more than one mechanism.
Normally speaking, one would have expected this combination to be very irritating, since the pH of this solu-tion is very acidic. We have also found that raising the p~ alone is not enough to alleviate the irritation response.
However, we have also discovered that the use of divalent oxides or hydroxides in combination with small amounts of glycine solve this problem. The alkali earth metal salts or glycine alone can improve the irritation potential problem somewhat, however, it can be essentially eliminated completely with the combination of the divalent metal oxides or hydroxides and glycine used in line with the instant discovery.
The quantity of the aluminum chloride that may be contained in the compositions of the present invention may vary somewhat. For the most part, they will constitute between about 5 and about 25~ by weight based on the total weight of the composition and preferably 7.5% to about 15~
by weight. As used herein, the term "an aluminum chloride"
is intended to refer to anhydrous aluminum chloride as well as its hydrated and hydroxide forms e.g. AlC13 . 6H2O or A12(OH)5Cl.
The aluminum zirconium hydroxychlorides that are employed in the present invention are well known in the prior art and be described by the general formula:
A14 Zn(OH)14-n Cln x H2 wherein n has the value 0 to 14 and x has the value o~ from O to 20. By way of example, mention may be made o~ compounds 47C~
of formulas:
A14 ZrO (OH)ll C13 ; and Al ZrO (OH)10 C14 and their corresponding hydrates.
The amount of the al~minum zirconium hydroxychloride that may be contained in the composition of this invention may also vary somewhat. Usually, however, it will comprise between about 2~ to about 20% by weight based on the total weight of the composition and preferably between about 5%
to about lQ~.
An important feature of the present compositions is the ratio of the aluminum salt and the Al/Zr salt that they contain. This ratio will be in the range of from about 0.5 to about 2; the preferred range being ~rom about 1.25 to about 1.75.
Another important relationship in the present compo-sitions is the metal:chloride mole ratio. It is important that this be less than ~9 to retain the ionic character of the complex which is related to its antiperspirant activity.
As indicated previously, it is highly advantageous to use a combination o~ magnesium hydroxide (or oxide) and glycine to adjust the pH of our compositions. This combina-tion will ordinarily be used to adjust the pH in the range of from abo~t 2.5 to about 4.5. The glycine will be employed at a level of from about 0.25% to about 5% by weight based on the total weight of the composition; whereas, the magnesium hydroxide (or oxide) will constitute about 1% to about 9~.
The ratio of glycine t~ magnesium ~ydroxide (or oxide) is also an important factox. This ratio may be in the range of from about .025 to about 5 but we prefer to employ a ratio in the range of from about 0.1 to about 1Ø
The novel combination of antipexspirant materials and the pH adjusting agents described above may be incorpora~ed ~L~471) in any of a variety of dosage forms useful for delivering the antiperspirant material. They may be incorporated in a lotion, in a cream or gel, in a foam system, in an aerosol dispensing system, in a pump spray system, as part of an antiperspirant stick or may be delivered in the form of a solution in a sui~able solvent vehicle. The following are illustrations of types of formulas in which the present compositions may be employed as active antiperspirant materials:
A. Roll-On (Lotions and Creams) Actives 25%
Emollients 2-4%
Surface active agents 2-4%
Buffering systems 2-7%
Water q.s. 100%
B. Suspension-Anhydrous can be used in the formulation of Aerosols and Aerosol Foams Actives 25~
Emollients 5-15%
Suspending agents 2-5~
Buffering agents 2-4%
Water q.s. 100~
Aarosol Above 70-85%
Propellant 15-30%
C~ Sticks Actives 25%
Gelling agent 2-4%
Waxes 5-20~
Emollients 5-20%
Buffering agents 2-4%
Externalphase q.s. 100%
* Anhydrous solvent V47C) ~he following Examples axe given to further illus-trate the present invention. It is understood, however, that th~ invention is not limited thereto.
Roll-On Lotion (Emulsion o/w) % by Wt.
AlC13 6H2O 15.00 Mg(OH)2 3.75 Al/Zr trichlorohydrat2l10.00 Brij 72 (Polyoxyethylene
ANTIPERSPIRANT CO~D?OSITION CONTAINING AS
ACTIVE ANTIPERSPIR~NT AGENTS AN ALU~INUM CHLORIDE
AND AN ALUMINUM ZIRCONIUM HYDROXYCHLORIDE AND METHOD
This invention relates to novel antiperspirant compositions. More particularly, it concerns antiperspir-ant compositions containing as active ingredients a com-bination of an aluminum chloride and an aluminum zirconium hydroxychloride.
It is known in the prior art to use aluminum chloride or aluminum zirconium hydroxychlorida individually as anti-perspirant materials. We have now found 7 however, when these materials are employed together they act syneryis-tically giving unexpected high activity and response rate.
It is accordingly an object of the present invention to provide a high performance antiperspirant composition containiny as active antiperspirant material a combination of an alumînum chloride and an al~lminum zirconium hydroxy-chloride.
It is also an object of the present invention to provide a method for inhibiting perspiration in subjects by applying to the skin of such subjects an antiperspirant effective amount of compositions containing in combination an aluminum chloride and an aluminum zirconium hydroxychloride.
Other and more d~tailed objects o~ this invention will be apparent from the following description and claims.
Unless otherwise indicated the percentages are given in percent by weight based on the total weight of the compo-sition.
It is known that certain types of people will respond to particular types of antiperspirant salts; it being unusual to find more than 60-70% of an antiperspirant panel respond-ing to any one given material. However, when the combination of active ingredients of this invention was used over 93%
of the panel participants responded favorably. Additionally, surprisingly high activities were recorded; 88~ had superior activity. It has always been believed that the activity mechanism for different salts differ~ What has been dis-covered here is a combination product that allows activity responses from more than one mechanism.
Normally speaking, one would have expected this combination to be very irritating, since the pH of this solu-tion is very acidic. We have also found that raising the p~ alone is not enough to alleviate the irritation response.
However, we have also discovered that the use of divalent oxides or hydroxides in combination with small amounts of glycine solve this problem. The alkali earth metal salts or glycine alone can improve the irritation potential problem somewhat, however, it can be essentially eliminated completely with the combination of the divalent metal oxides or hydroxides and glycine used in line with the instant discovery.
The quantity of the aluminum chloride that may be contained in the compositions of the present invention may vary somewhat. For the most part, they will constitute between about 5 and about 25~ by weight based on the total weight of the composition and preferably 7.5% to about 15~
by weight. As used herein, the term "an aluminum chloride"
is intended to refer to anhydrous aluminum chloride as well as its hydrated and hydroxide forms e.g. AlC13 . 6H2O or A12(OH)5Cl.
The aluminum zirconium hydroxychlorides that are employed in the present invention are well known in the prior art and be described by the general formula:
A14 Zn(OH)14-n Cln x H2 wherein n has the value 0 to 14 and x has the value o~ from O to 20. By way of example, mention may be made o~ compounds 47C~
of formulas:
A14 ZrO (OH)ll C13 ; and Al ZrO (OH)10 C14 and their corresponding hydrates.
The amount of the al~minum zirconium hydroxychloride that may be contained in the composition of this invention may also vary somewhat. Usually, however, it will comprise between about 2~ to about 20% by weight based on the total weight of the composition and preferably between about 5%
to about lQ~.
An important feature of the present compositions is the ratio of the aluminum salt and the Al/Zr salt that they contain. This ratio will be in the range of from about 0.5 to about 2; the preferred range being ~rom about 1.25 to about 1.75.
Another important relationship in the present compo-sitions is the metal:chloride mole ratio. It is important that this be less than ~9 to retain the ionic character of the complex which is related to its antiperspirant activity.
As indicated previously, it is highly advantageous to use a combination o~ magnesium hydroxide (or oxide) and glycine to adjust the pH of our compositions. This combina-tion will ordinarily be used to adjust the pH in the range of from abo~t 2.5 to about 4.5. The glycine will be employed at a level of from about 0.25% to about 5% by weight based on the total weight of the composition; whereas, the magnesium hydroxide (or oxide) will constitute about 1% to about 9~.
The ratio of glycine t~ magnesium ~ydroxide (or oxide) is also an important factox. This ratio may be in the range of from about .025 to about 5 but we prefer to employ a ratio in the range of from about 0.1 to about 1Ø
The novel combination of antipexspirant materials and the pH adjusting agents described above may be incorpora~ed ~L~471) in any of a variety of dosage forms useful for delivering the antiperspirant material. They may be incorporated in a lotion, in a cream or gel, in a foam system, in an aerosol dispensing system, in a pump spray system, as part of an antiperspirant stick or may be delivered in the form of a solution in a sui~able solvent vehicle. The following are illustrations of types of formulas in which the present compositions may be employed as active antiperspirant materials:
A. Roll-On (Lotions and Creams) Actives 25%
Emollients 2-4%
Surface active agents 2-4%
Buffering systems 2-7%
Water q.s. 100%
B. Suspension-Anhydrous can be used in the formulation of Aerosols and Aerosol Foams Actives 25~
Emollients 5-15%
Suspending agents 2-5~
Buffering agents 2-4%
Water q.s. 100~
Aarosol Above 70-85%
Propellant 15-30%
C~ Sticks Actives 25%
Gelling agent 2-4%
Waxes 5-20~
Emollients 5-20%
Buffering agents 2-4%
Externalphase q.s. 100%
* Anhydrous solvent V47C) ~he following Examples axe given to further illus-trate the present invention. It is understood, however, that th~ invention is not limited thereto.
Roll-On Lotion (Emulsion o/w) % by Wt.
AlC13 6H2O 15.00 Mg(OH)2 3.75 Al/Zr trichlorohydrat2l10.00 Brij 72 (Polyoxyethylene
2 Stearyl Ether) 3.00 Brij 78 (Polyoxyethylene 20 Stearyl Ether) 1.00 Glycine 0.50 Disodium EDTA 0.10 Polyoxypropylene 15 *
Stearyl Ether tArlamol E) 4.00 H2O 62.65 100 . 00 Clear Water Solution (Pump Spray) AlC13 . 6H2O 15.00 Mg(OH)2 3.75 Glycine 0.50 Al/Zr trichlorohydrate110.00 H2O 65.75 .* *
Procetyl AWS (PPG-5 Cetheth 20) 5.00 100. 00 EXAMP~E 3 Aerosol Antiperspirant Al/Complex Powder2 6.00 Al/Zr trichlorohydratel 4.00 Di.butyl phthalate 11.00 1 A14ZrO(OH)llCl3 2 Product p~e?ared by spray drying AlC13; M (OH)2 and glycine ir.
t~e weight ratio o~ 4:~: .5 g *Trademark B
EXAMPLE 3 (Cont'd ?
*
Cabosil M-5 0.30 Be~one 34 0.10 Isobutane 78.60 100.00 ExAMæLE 4 Stick Antiperspirant Al/Complex Powder 15.00 Al/Zr trichlorohydrate 10.00 Stearyl alcohol 20.00 Dibutyl phthalate 41.00 Proce~yl AWS (PPG-5 Cetheth ~0) 10.00 Montan wax 4.00 100. 00 To demonstrate the fact that the combination of the aluminum chloride and the aluminum zirconium hydroxychloride act synergistically as antiperspirants, thxee compositions were prepared identified as Compositions A, B and C which were the same in all respects excepting the active antiper-~0 spirant ma~erial~ Composition A contained 25% by weight of aluminum zirconium hydroxychloride; Composition B con-tained 10% by weight o~ aluminum zirconium hydroxychloride and 15% by weight o~ aluminum chloride; and Composition C
contained 25% by weight of al~minum chloride. Each of these compositions were tested for antiperspirant activity on a group of individuals that served as an antiperspirant panel.
The procedure employed was as described in Federal Register, Vol~ 43, Number 196, October 10, 1978 and is called the Gravemetric Axillary Antiperspirant Test.
The results of this test are summarized in Table I
below which gives the formulas o~ Compositions A, B and C
*Trademark $ ```
..~ ,~
7~) as well as the antiperspirant activity measured or each composition.
TABLE I
A B C
Aluminum Zirconium hydroxide Complex 25 lO --Aluminum Chloride -- 15 25 Emollient 2-4 2-4 2-4 Surface Active Agents 2-4 2-4 2-4 q.s. buffer to pH
Stearyl Ether tArlamol E) 4.00 H2O 62.65 100 . 00 Clear Water Solution (Pump Spray) AlC13 . 6H2O 15.00 Mg(OH)2 3.75 Glycine 0.50 Al/Zr trichlorohydrate110.00 H2O 65.75 .* *
Procetyl AWS (PPG-5 Cetheth 20) 5.00 100. 00 EXAMP~E 3 Aerosol Antiperspirant Al/Complex Powder2 6.00 Al/Zr trichlorohydratel 4.00 Di.butyl phthalate 11.00 1 A14ZrO(OH)llCl3 2 Product p~e?ared by spray drying AlC13; M (OH)2 and glycine ir.
t~e weight ratio o~ 4:~: .5 g *Trademark B
EXAMPLE 3 (Cont'd ?
*
Cabosil M-5 0.30 Be~one 34 0.10 Isobutane 78.60 100.00 ExAMæLE 4 Stick Antiperspirant Al/Complex Powder 15.00 Al/Zr trichlorohydrate 10.00 Stearyl alcohol 20.00 Dibutyl phthalate 41.00 Proce~yl AWS (PPG-5 Cetheth ~0) 10.00 Montan wax 4.00 100. 00 To demonstrate the fact that the combination of the aluminum chloride and the aluminum zirconium hydroxychloride act synergistically as antiperspirants, thxee compositions were prepared identified as Compositions A, B and C which were the same in all respects excepting the active antiper-~0 spirant ma~erial~ Composition A contained 25% by weight of aluminum zirconium hydroxychloride; Composition B con-tained 10% by weight o~ aluminum zirconium hydroxychloride and 15% by weight o~ aluminum chloride; and Composition C
contained 25% by weight of al~minum chloride. Each of these compositions were tested for antiperspirant activity on a group of individuals that served as an antiperspirant panel.
The procedure employed was as described in Federal Register, Vol~ 43, Number 196, October 10, 1978 and is called the Gravemetric Axillary Antiperspirant Test.
The results of this test are summarized in Table I
below which gives the formulas o~ Compositions A, B and C
*Trademark $ ```
..~ ,~
7~) as well as the antiperspirant activity measured or each composition.
TABLE I
A B C
Aluminum Zirconium hydroxide Complex 25 lO --Aluminum Chloride -- 15 25 Emollient 2-4 2-4 2-4 Surface Active Agents 2-4 2-4 2-4 q.s. buffer to pH
3.2 + .3 q.s. water to 100%
pH at time of test ~ 3.5 3.2 3.4 Activity 50% 62% 53%
As will be seen fro~ the above Table, a 20-25~ enhance-ment of antiperspirant activity is obtained with a combination of aluminum chloride and aluminum zirconium hydroxychloride as compared with the use of aluminum chloride or aluminum zirconium hydroxychloride.
Although the invention has been described with reference to specific forms thereof, it will be understood that many changes and modifications may be made without departing ~rom the spirit of this invention.
pH at time of test ~ 3.5 3.2 3.4 Activity 50% 62% 53%
As will be seen fro~ the above Table, a 20-25~ enhance-ment of antiperspirant activity is obtained with a combination of aluminum chloride and aluminum zirconium hydroxychloride as compared with the use of aluminum chloride or aluminum zirconium hydroxychloride.
Although the invention has been described with reference to specific forms thereof, it will be understood that many changes and modifications may be made without departing ~rom the spirit of this invention.
Claims (9)
1. An antiperspirant composition comprising a carrier and as active antiperspirant material a combination of an aluminum chloride and an aluminum zirconium hydroxy-chloride, said antiperspirant material comprising, based on the total weight of the composition, from about 5% to about 25%
by weight of an aluminum chloride and from about 7.5% to about 15% by weight of an aluminum zirconium hydroxychloride; the ratio of aluminum salt to Al/Zr salt in said composition being in the range of from about 0.5 to about 2 and the mole ratio of metal to chloride being less than .9.
by weight of an aluminum chloride and from about 7.5% to about 15% by weight of an aluminum zirconium hydroxychloride; the ratio of aluminum salt to Al/Zr salt in said composition being in the range of from about 0.5 to about 2 and the mole ratio of metal to chloride being less than .9.
2. A composition according to Claim 1 including as a pH adjusting agent a combination of magnesium hydroxide or oxide and glycine, said magnesium hydroxide or oxide constituting from about 1% to about 9% by weight of said composition and said glycine constituting from about 0.25%
to about 5% by weight of said composition.
to about 5% by weight of said composition.
3. A composition according to Claim 1 in the form of a lotion.
4. A composition according to Claim 1 in the form of a solution.
5. A composition according to Claim 1 in the form of a stick.
6. A composition according to Claim 1 in the form of an aerosol composition.
7. A composition according to Claim 1 in the form of a pump spray composition.
8. A composition according to Claim 1 in the form of a cream or a gel.
9. A composition according to Claim 1 in the form of a foam.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15311380A | 1980-05-27 | 1980-05-27 | |
| US153,113 | 1980-05-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1140470A true CA1140470A (en) | 1983-02-01 |
Family
ID=22545825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000355786A Expired CA1140470A (en) | 1980-05-27 | 1980-07-09 | Aluminum chloride and aluminum zirconium hydroxychloride as antiperspirant |
Country Status (17)
| Country | Link |
|---|---|
| JP (1) | JPS5711908A (en) |
| AU (1) | AU547530B2 (en) |
| BE (1) | BE888975A (en) |
| CA (1) | CA1140470A (en) |
| CH (1) | CH644755A5 (en) |
| DE (1) | DE3120742A1 (en) |
| FR (1) | FR2483230A1 (en) |
| GB (1) | GB2076289B (en) |
| GR (1) | GR75643B (en) |
| IT (1) | IT1170993B (en) |
| MX (1) | MX156358A (en) |
| NL (1) | NL8102540A (en) |
| NZ (1) | NZ197164A (en) |
| PH (1) | PH16329A (en) |
| PT (1) | PT73090B (en) |
| SE (1) | SE452107B (en) |
| ZA (1) | ZA813484B (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1153313A (en) * | 1980-12-15 | 1983-09-06 | Chung T. Shin | Antiperspirant composition containing aluminum chlorohydrate, aluminum chloride and an aluminum zirconium polychlorohydrate complex and method of use |
| US4774079A (en) * | 1980-12-15 | 1988-09-27 | Bristol-Myers Company | Antiperspirant composition containing aluminum chlorohydrate, aluminum chloride and an aluminum zirconium polychlorohydrate complex and method of use |
| US4606915A (en) * | 1981-04-23 | 1986-08-19 | Bristol-Myers Company | Antiperspirant combination containing an aluminum halohydrate and a stannic halide |
| US5589196A (en) * | 1983-08-16 | 1996-12-31 | The Gillette Company | Antiperspirant composition |
| US5114705A (en) * | 1983-08-16 | 1992-05-19 | The Gillette Company | Antiperspirant composition |
| GB2144992A (en) * | 1983-08-16 | 1985-03-20 | Gillette Co | Antiperspirants |
| US4775528A (en) * | 1983-08-16 | 1988-10-04 | The Gillette Company | Antiperspirant composition |
| US4673570A (en) * | 1985-03-20 | 1987-06-16 | Carter-Wallace, Inc. | Gelled antiperspirant compositions |
| JPH05112440A (en) * | 1991-08-09 | 1993-05-07 | Sayuri Takemoto | Coating agent for deodorization |
| US6136302A (en) * | 1999-02-18 | 2000-10-24 | The Procter & Gamble Company | Process of making zirconium-aluminum antiperspirant active |
| US6375937B1 (en) | 2000-10-20 | 2002-04-23 | Colgate-Palmolive Company | Antiperspirant salts for enhanced cosmetic products |
| FR2828646B1 (en) † | 2001-08-17 | 2004-11-26 | Oreal | ANHYDROUS ANTITRANSPIRANT STICK |
| US20040109833A1 (en) | 2002-12-09 | 2004-06-10 | Xiaozhong Tang | High efficacy, low irritation aluminum salts and related products |
| CA2544215A1 (en) * | 2003-11-17 | 2005-06-02 | The Procter & Gamble Company | Antiperspirant composition and applicator therefor |
| EP2516017B1 (en) * | 2009-12-23 | 2018-02-21 | Colgate-Palmolive Company | Method of making an anhydrous liquid antiperspirant composition |
| EP3071300B1 (en) | 2013-11-18 | 2019-03-27 | Colgate-Palmolive Company | Antiperspirant composition |
| AU2015363613B2 (en) | 2014-12-15 | 2018-12-13 | Unilever Global Ip Limited | Antiperspirant compositions comprising alums |
| US9572758B2 (en) | 2015-06-30 | 2017-02-21 | Gulbrandsen Technologies, Inc. | Method of making high performance activated aluminum sesquichlorohydrate powders |
| US20170128332A1 (en) * | 2015-11-09 | 2017-05-11 | Gulbrandsen Technologies, Inc. | Activation and stabilization of basic aluminum chloride solution by zinc |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2906668A (en) * | 1955-06-13 | 1959-09-29 | Reheis Company Inc | Zirconyl and aluminum halohydroxy complex |
| US3903258A (en) * | 1973-08-06 | 1975-09-02 | Gillette Co | Zirconium aluminum complexes and method of making the same |
| US3981986A (en) * | 1973-11-23 | 1976-09-21 | Armour Pharmaceutical Company | Zirconium-aluminum-polyol buffered anti-perspirant complexes |
| US4017599A (en) * | 1973-11-23 | 1977-04-12 | Armour Pharmaceutical Company | Aluminum-zirconium anti-perspirant systems with salts of amino acids |
| AU8303275A (en) * | 1974-07-17 | 1977-01-20 | Armour Pharma | Aluminum-zirconium antiperspirant systems with trace amounts of alkaline earth metals |
| JPS5454863A (en) * | 1977-10-03 | 1979-05-01 | Kubota Ltd | Stalk and straw conveying apparatus with safety cover |
-
1980
- 1980-07-09 CA CA000355786A patent/CA1140470A/en not_active Expired
-
1981
- 1981-05-21 AU AU70928/81A patent/AU547530B2/en not_active Ceased
- 1981-05-21 NZ NZ197164A patent/NZ197164A/en unknown
- 1981-05-22 FR FR8110236A patent/FR2483230A1/en active Granted
- 1981-05-22 NL NL8102540A patent/NL8102540A/en not_active Application Discontinuation
- 1981-05-22 GR GR65041A patent/GR75643B/el unknown
- 1981-05-25 IT IT48527/81A patent/IT1170993B/en active
- 1981-05-25 DE DE19813120742 patent/DE3120742A1/en active Granted
- 1981-05-25 ZA ZA00813484A patent/ZA813484B/en unknown
- 1981-05-26 PT PT73090A patent/PT73090B/en unknown
- 1981-05-26 MX MX187478A patent/MX156358A/en unknown
- 1981-05-26 BE BE0/204911A patent/BE888975A/en not_active IP Right Cessation
- 1981-05-26 GB GB8116054A patent/GB2076289B/en not_active Expired
- 1981-05-26 CH CH345681A patent/CH644755A5/en not_active IP Right Cessation
- 1981-05-27 SE SE8103369A patent/SE452107B/en not_active IP Right Cessation
- 1981-05-27 JP JP7944281A patent/JPS5711908A/en active Granted
- 1981-05-27 PH PH25676A patent/PH16329A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB2076289B (en) | 1985-01-09 |
| FR2483230B1 (en) | 1985-01-04 |
| ZA813484B (en) | 1982-05-26 |
| NL8102540A (en) | 1981-12-16 |
| PH16329A (en) | 1983-09-05 |
| IT1170993B (en) | 1987-06-03 |
| DE3120742C2 (en) | 1988-10-27 |
| BE888975A (en) | 1981-11-26 |
| SE452107B (en) | 1987-11-16 |
| JPS5711908A (en) | 1982-01-21 |
| IT8148527A0 (en) | 1981-05-25 |
| PT73090A (en) | 1981-06-01 |
| JPS6412245B2 (en) | 1989-02-28 |
| AU7092881A (en) | 1981-12-03 |
| AU547530B2 (en) | 1985-10-24 |
| NZ197164A (en) | 1984-08-24 |
| SE8103369L (en) | 1981-11-28 |
| GB2076289A (en) | 1981-12-02 |
| DE3120742A1 (en) | 1982-03-18 |
| CH644755A5 (en) | 1984-08-31 |
| GR75643B (en) | 1984-08-02 |
| FR2483230A1 (en) | 1981-12-04 |
| MX156358A (en) | 1988-08-12 |
| PT73090B (en) | 1983-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1140470A (en) | Aluminum chloride and aluminum zirconium hydroxychloride as antiperspirant | |
| US4065564A (en) | Antiperspirant solution containing a substantially non-volatile siloxane liquid | |
| US4073880A (en) | Antiperspirant solution containing a substantially volatile polydimethyl siloxane liquid | |
| AU2019201158B2 (en) | Zinc phosphate complex | |
| US4021536A (en) | Magnesium-zirconium complexes useful as antiperspirants | |
| AU2022287610A1 (en) | An antiperspirant composition | |
| AU2021393976B2 (en) | An antiperspirant composition | |
| EP3233207B1 (en) | Personal care compositions with zinc phosphate active | |
| EP4013379B1 (en) | No staining antiperspirant composition | |
| WO2019206764A1 (en) | An antiperspirant composition | |
| EP3941593B1 (en) | An antiperspirant composition comprising reactive salts | |
| EP3941594B1 (en) | An antiperspirant composition comprising reactive salts | |
| EP0272354B1 (en) | Antiperspirant product | |
| EP0319168A1 (en) | Antiperspirant compositions | |
| US5135741A (en) | Antiperspirant product | |
| US20230293400A1 (en) | An Antiperspirant Composition | |
| US4490354A (en) | Antiperspirant method containing vanadium salts | |
| GB835385A (en) | Antiperspirant compounds | |
| JP2018203683A (en) | Antiperspirant composition | |
| US12156928B2 (en) | Antiperspirant composition comprising inorganic polyionic cluster | |
| NZ199507A (en) | Antiperspirant compositions containing an aluminium halohydrate and a stannic halide | |
| AU2018363128B2 (en) | Antimicrobial antiperspirant compositions | |
| US20240082126A1 (en) | An anhydrous antiperspirant composition | |
| AU2012314737A1 (en) | Antiperspirant compositions and method for reducing perspiration | |
| TH1162B (en) | The composition of antiperspirant deodorant consists of an antiperspirant, aluminum chloride and aluminum zirconium hodroxycrochloride, and the method of use of these ingredients. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |